1,939
Views
3
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Number needed to treat based on real-world evidence for non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in stroke prevention in patients with non-valvular atrial fibrillation

, , , , & ORCID Icon
Pages 760-765 | Received 15 Jan 2019, Accepted 03 Apr 2019, Published online: 03 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

William L. Baker, Matthew S. Roberts, Youssef Bessada, Kimberly S. Caroti, Veronica Ashton, Brahim K. Bookhart & Craig I. Coleman. (2023) Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: a systematic review of observational studies. Current Medical Research and Opinion 39:9, pages 1183-1194.
Read now

Articles from other publishers (2)

Paula Hernández, Lucia Polanco, Ignacio Santiago, Marina Fayos & Carmen Valero. (2021) Evolución temporal de los cambios en el tratamiento anticoagulante en un hospital terciario. Medicina Clínica 156:3, pages 135-138.
Crossref
Paula Hernández, Lucia Polanco, Ignacio Santiago, Marina Fayos & Carmen Valero. (2021) Progression over time of changes in anticoagulant treatment in a tertiary hospital. Medicina Clínica (English Edition) 156:3, pages 135-138.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.